Cargando…

Clinical and immunological effects of anti-TNF therapy in systemic lupus erythematosus (SLE)

Detalles Bibliográficos
Autores principales:	Aringer, M, Steiner, G, Graninger, WB, Höfler, E, Hiesberger, H, Steiner, C-W, Smolen, J
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2003
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2833600/ http://dx.doi.org/10.1186/ar663

Ejemplares similares

T lymphocytes of patients with SLE lack Stat4
por: Aringer, M, et al.
Publicado: (2001)

Comparative analysis of anti-histone and anti-chromatin antibody specificity in lupus erythematosus cell-positive and -negative sera and their relation to disease activity
por: Schett, G, et al.
Publicado: (2001)

Enhanced transendothelial in vitro migration of scleroderma lymphocytes
por: Stummvoll, GH, et al.
Publicado: (2001)

Comparison of different immunoassays detecting anti-chromatin autoantibodies in systemic lupus erythematosus (SLE)
por: Roux-Lombard, P, et al.
Publicado: (2002)

Autoantibodies to the TNF-α translational regulators TIA-1 and TIAR occur frequently in sera of patients with SLE and scleroderma
por: Jimenez-Boj, E, et al.
Publicado: (2002)

SLE - Complex cytokine effects in a complex autoimmune disease: tumor necrosis factor in systemic lupus erythematosus
por: Aringer, Martin, et al.
Publicado: (2003)

Analysis of anti-Ro52 antibodies in sera of healthy subjects
por: Zimmermann, C, et al.
Publicado: (2001)

Impaired T-cell rsponse to subsequent TCR-stimulation after anti-CD3 induced proliferation
por: Köller, MD, et al.
Publicado: (2001)

Stat1 and phosphorylated Stat1 are increased in lymphocytes and monocytes of patients with systemic lupus erythematosus
por: Aringer, M, et al.
Publicado: (2005)

Repair of local bone erosions and reversal of systemic bone loss upon therapy with anti-TNF in combination with OPG or PTH in TNF-mediated arthritis
por: Redlich, K, et al.
Publicado: (2004)

The diagnostic significance of autoantibodies in patients with very early rheumatoid arthritis
por: Nell, V, et al.
Publicado: (2003)

Vasculitis and Systemic Lupus Erythematous (SLE)
por: Cortis, Elisabetta, et al.
Publicado: (2015)

Autoreactive T cells to histone H1 and core histones in patients with systemic lupus erythematosus
por: Stummvoll, GH, et al.
Publicado: (2005)

Effects of atacicept on disease activity in patients with moderate to severe systemic lupus erythematosus: APRIL-SLE randomized trial
por: Isenberg, David, et al.
Publicado: (2014)

Clinical and immunological response to pneumococcal vaccination in pediatric systemic lupus erythematosus
por: Rigdon, D, et al.
Publicado: (2012)

Characterization of RA33 (hnRNP-A2/B1)-autoreactive T cells in SLE-patients
por: Fritsch, R, et al.
Publicado: (2001)

Autoantibodies to the mRNA destabilizing protein hnRNP-D/AUF1 in patients with systemic autoimmune diseases
por: Skriner, K, et al.
Publicado: (2001)

Chondrocyte number and proteoglycan synthesis in the ageing and osteoarthritic human articular cartilage
por: Bobacz, K, et al.
Publicado: (2003)

Autoantibodies to hnRNP-A2 in SLE: identification of disease-specific linear epitopes and correlation with disease activity and clinical features
por: Schett, G, et al.
Publicado: (2003)

Overexpression of TNF causes bilateral sacroiliitis
por: Redlich, K, et al.
Publicado: (2004)

The role of tumor necrosis factor-alpha in systemic lupus erythematosus
por: Aringer, Martin, et al.
Publicado: (2008)

Phenotypic and functional deficiencies of monocyte derived dendritic cells in systemic lupus erythematosus patients
por: Scheinecker, C, et al.
Publicado: (2004)

Protein microarray characterization of autoantibody responses in rheumatoid arthritis and systemic lupus erythematosus
por: Robinson, W, et al.
Publicado: (2002)

Adenoviral-based overexpression of TIMP-1 reduces tissue damage in the joints TNF-transgenic mice
por: Schett, G, et al.
Publicado: (2001)

Isolated and combined inhibition of TNF-, IL-1 and RANKL-pathways in TNF-induced arthritis: effects on synovial inflammation, bone erosion and cartilage destruction
por: Zwerina, J, et al.
Publicado: (2003)

Osteoclasts are essential for TNF-mediated joint destruction
por: Redlich, KR, et al.
Publicado: (2002)

Protein microarray characterization of the autoantibody response in systemic lupus erythematosus and related diseases
por: Robinson, W, et al.
Publicado: (2001)

Osteoprotegerin protects from generalized bone loss in TNF-transgenic mice
por: Hayer, S, et al.
Publicado: (2003)

Systemic Lupus Erythematosus (SLE) Therapy: The Old and the New
por: Basta, Fabio, et al.
Publicado: (2020)

Effect of osteoprotegerin and pamidronate treatment in transgenic mice overexpressing human TNF
por: Redlich, K, et al.
Publicado: (2001)

Association of anti-ribosomal P protein antibodies with neuropsychiatric systemic lupus erythematosus
por: Ambrozic, A, et al.
Publicado: (2004)

Role of anti-Ro autoantibodies in systemic lupus erythematosus patients with recurrent myositis
por: Umer, S, et al.
Publicado: (2012)

Lung cancer in systemic lupus erythematosus
por: Kale, M, et al.
Publicado: (2012)

Blimp-1 and systemic lupus erythematosus
por: Diamond, Betty, et al.
Publicado: (2014)

Immuno-serological profile of Systemic Erythemic Lupus (SLE) patients with neuropsychiatric manifestations (NP)
por: Stojanovich, L, et al.
Publicado: (2001)

Anti-TNF-α Therapies in Systemic Lupus Erythematosus
por: Zhu, Lang-Jing, et al.
Publicado: (2010)

Prevalence of angina in patients with systemic lupus erythematosus
por: Ishimori, ML, et al.
Publicado: (2012)

Nonlymphoma hematological malignancies in systemic lupus erythematosus
por: Lu, M, et al.
Publicado: (2012)

Is prevention of systemic lupus erythematosus a goal?
por: Olsen, Nancy J, et al.
Publicado: (2014)

Development of targeted biologics for systemic lupus erythematosus
por: Lipsky, Peter E
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_q4jji36hf16k406bb9j735m7qh